PERTH, Australia, March 17, 2026 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end Contract Development and Manufacturing Organisation (CDMO) announced it has initiated a comprehensive CMC ...
The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...
The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...
As the demand for biologics accelerates, biopharma companies are under pressure to expand sterile manufacturing capacity ...
Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drug Product Manufacturing Market Overview and Outlook" report has been added to ResearchAndMarkets.com's offering. Current demand for ...
WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...
-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...
Afton Scientific, a CDMO, plans to shell out $200 million to expand its manufacturing plant in Charlottesville, Virginia, as part of a project that includes hiring 200 new workers. The company, which ...
WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility in Whippany, New Jersey, by adding sterile injectable manufacturing ...
Mark Cuban Cost Plus Drug Company will begin manufacturing its own generic medications this week, starting with sterile injectables, founder and CEO Alex Oshmyansky, M.D., Ph.D., said Monday during a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results